Click for best price
Prostate Cancer Treatment Drugs Market Size, Share 2022
Adoption of innovative technologies in screening & diagnostic tests is projected to drive growth. The incorporation of multiparametric MRI (mp-MRI) can significantly improve the detection of tumor and also provide confirmation whether there is a need for tissue biopsy. In addition, market players are investing in research for the development of therapeutic products for the treatment of such tumors. For instance, there is a strong pipeline of products such as Tc-99m (Progenics), radium-223 dichloride (Xofigo, Bayer), ODM-201 (Orion and Bayer), which are in their phase 3 studies and are projected to enter the market in the near future. In addition, many generic products are likely to enter the market owing to the expiry of patents of the major existing products during the forecast period. Thus, these factors are expected to drive growth.
This report contains market size and forecasts of Prostate Cancer Treatment Drugs in Global, including the following market information:
Global Prostate Cancer Treatment Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Prostate Cancer Treatment Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Zytiga Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Prostate Cancer Treatment Drugs include Johnson & Johnson, Astella, Sanofi, Ipsen, Bayer, AstraZeneca and Dendreon, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Prostate Cancer Treatment Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prostate Cancer Treatment Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Prostate Cancer Treatment Drugs Market Segment Percentages, by Type, 2021 (%)
Zytiga
Gonax
Lupron
Zoladex
Decapeptyl
Eligard
Vantas
Casodex
Others
Global Prostate Cancer Treatment Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Prostate Cancer Treatment Drugs Market Segment Percentages, by Application, 2021 (%)
Hospitals
Ambulatory Surgical Centers
Clinics
Global Prostate Cancer Treatment Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Prostate Cancer Treatment Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prostate Cancer Treatment Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Prostate Cancer Treatment Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Johnson & Johnson
Astella
Sanofi
Ipsen
Bayer
AstraZeneca
Dendreon
| Report Attributes |
Report Details |
| Report Title |
Prostate Cancer Treatment Drugs Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
62 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Prostate Cancer Treatment Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Prostate Cancer Treatment Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Prostate Cancer Treatment Drugs Overall Market Size
2.1 Global Prostate Cancer Treatment Drugs Market Size: 2021 VS 2028
2.2 Global Prostate Cancer Treatment Drugs Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Prostate Cancer Treatment Drugs Players in Global Market
3.2 Top Global Prostate Cancer Treatment Drugs Companies Ranked by Revenue
3.3 Global Prostate Cancer Treatment Drugs Revenue by Companies
3.4 Top 3 and Top 5 Prostate Cancer Treatment Drugs Companies in Global Market, by Revenue in 2021
3.5 Global Companies Prostate Cancer Treatment Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Prostate Cancer Treatment Drugs Players in Global Market
3.6.1 List of Global Tier 1 Prostate Cancer Treatment Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Prostate Cancer Treatment Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Prostate Cancer Treatment Drugs Market Size Markets, 2021 & 2028
4.1.2 Zytiga
4.1.3 Gonax
4.1.4 Lupron
4.1.5 Zoladex
4.1.6 Decapeptyl
4.1.7 Eligard
4.1.8 Vantas
4.1.9 Casodex
4.1.10 Others
4.2 By Type - Global Prostate Cancer Treatment Drugs Revenue & Forecasts
4.2.1 By Type - Global Prostate Cancer Treatment Drugs Revenue, 2017-2022
4.2.2 By Type - Global Prostate Cancer Treatment Drugs Revenue, 2023-2028
4.2.3 By Type - Global Prostate Cancer Treatment Drugs Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Prostate Cancer Treatment Drugs Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Ambulatory Surgical Centers
5.1.4 Clinics
5.2 By Application - Global Prostate Cancer Treatment Drugs Revenue & Forecasts
5.2.1 By Application - Global Prostate Cancer Treatment Drugs Revenue, 2017-2022
5.2.2 By Application - Global Prostate Cancer Treatment Drugs Revenue, 2023-2028
5.2.3 By Application - Global Prostate Cancer Treatment Drugs Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Prostate Cancer Treatment Drugs Market Size, 2021 & 2028
6.2 By Region - Global Prostate Cancer Treatment Drugs Revenue & Forecasts
6.2.1 By Region - Global Prostate Cancer Treatment Drugs Revenue, 2017-2022
6.2.2 By Region - Global Prostate Cancer Treatment Drugs Revenue, 2023-2028
6.2.3 By Region - Global Prostate Cancer Treatment Drugs Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Prostate Cancer Treatment Drugs Revenue, 2017-2028
6.3.2 US Prostate Cancer Treatment Drugs Market Size, 2017-2028
6.3.3 Canada Prostate Cancer Treatment Drugs Market Size, 2017-2028
6.3.4 Mexico Prostate Cancer Treatment Drugs Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Prostate Cancer Treatment Drugs Revenue, 2017-2028
6.4.2 Germany Prostate Cancer Treatment Drugs Market Size, 2017-2028
6.4.3 France Prostate Cancer Treatment Drugs Market Size, 2017-2028
6.4.4 U.K. Prostate Cancer Treatment Drugs Market Size, 2017-2028
6.4.5 Italy Prostate Cancer Treatment Drugs Market Size, 2017-2028
6.4.6 Russia Prostate Cancer Treatment Drugs Market Size, 2017-2028
6.4.7 Nordic Countries Prostate Cancer Treatment Drugs Market Size, 2017-2028
6.4.8 Benelux Prostate Cancer Treatment Drugs Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Prostate Cancer Treatment Drugs Revenue, 2017-2028
6.5.2 China Prostate Cancer Treatment Drugs Market Size, 2017-2028
6.5.3 Japan Prostate Cancer Treatment Drugs Market Size, 2017-2028
6.5.4 South Korea Prostate Cancer Treatment Drugs Market Size, 2017-2028
6.5.5 Southeast Asia Prostate Cancer Treatment Drugs Market Size, 2017-2028
6.5.6 India Prostate Cancer Treatment Drugs Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Prostate Cancer Treatment Drugs Revenue, 2017-2028
6.6.2 Brazil Prostate Cancer Treatment Drugs Market Size, 2017-2028
6.6.3 Argentina Prostate Cancer Treatment Drugs Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Prostate Cancer Treatment Drugs Revenue, 2017-2028
6.7.2 Turkey Prostate Cancer Treatment Drugs Market Size, 2017-2028
6.7.3 Israel Prostate Cancer Treatment Drugs Market Size, 2017-2028
6.7.4 Saudi Arabia Prostate Cancer Treatment Drugs Market Size, 2017-2028
6.7.5 UAE Prostate Cancer Treatment Drugs Market Size, 2017-2028
7 Players Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Corporate Summary
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Prostate Cancer Treatment Drugs Major Product Offerings
7.1.4 Johnson & Johnson Prostate Cancer Treatment Drugs Revenue in Global Market (2017-2022)
7.1.5 Johnson & Johnson Key News
7.2 Astella
7.2.1 Astella Corporate Summary
7.2.2 Astella Business Overview
7.2.3 Astella Prostate Cancer Treatment Drugs Major Product Offerings
7.2.4 Astella Prostate Cancer Treatment Drugs Revenue in Global Market (2017-2022)
7.2.5 Astella Key News
7.3 Sanofi
7.3.1 Sanofi Corporate Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Prostate Cancer Treatment Drugs Major Product Offerings
7.3.4 Sanofi Prostate Cancer Treatment Drugs Revenue in Global Market (2017-2022)
7.3.5 Sanofi Key News
7.4 Ipsen
7.4.1 Ipsen Corporate Summary
7.4.2 Ipsen Business Overview
7.4.3 Ipsen Prostate Cancer Treatment Drugs Major Product Offerings
7.4.4 Ipsen Prostate Cancer Treatment Drugs Revenue in Global Market (2017-2022)
7.4.5 Ipsen Key News
7.5 Bayer
7.5.1 Bayer Corporate Summary
7.5.2 Bayer Business Overview
7.5.3 Bayer Prostate Cancer Treatment Drugs Major Product Offerings
7.5.4 Bayer Prostate Cancer Treatment Drugs Revenue in Global Market (2017-2022)
7.5.5 Bayer Key News
7.6 AstraZeneca
7.6.1 AstraZeneca Corporate Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Prostate Cancer Treatment Drugs Major Product Offerings
7.6.4 AstraZeneca Prostate Cancer Treatment Drugs Revenue in Global Market (2017-2022)
7.6.5 AstraZeneca Key News
7.7 Dendreon
7.7.1 Dendreon Corporate Summary
7.7.2 Dendreon Business Overview
7.7.3 Dendreon Prostate Cancer Treatment Drugs Major Product Offerings
7.7.4 Dendreon Prostate Cancer Treatment Drugs Revenue in Global Market (2017-2022)
7.7.5 Dendreon Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Prostate Cancer Treatment Drugs Market Opportunities & Trends in Global Market
Table 2. Prostate Cancer Treatment Drugs Market Drivers in Global Market
Table 3. Prostate Cancer Treatment Drugs Market Restraints in Global Market
Table 4. Key Players of Prostate Cancer Treatment Drugs in Global Market
Table 5. Top Prostate Cancer Treatment Drugs Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Prostate Cancer Treatment Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Prostate Cancer Treatment Drugs Revenue Share by Companies, 2017-2022
Table 8. Global Companies Prostate Cancer Treatment Drugs Product Type
Table 9. List of Global Tier 1 Prostate Cancer Treatment Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Prostate Cancer Treatment Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Prostate Cancer Treatment Drugs Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Prostate Cancer Treatment Drugs Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Prostate Cancer Treatment Drugs Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Prostate Cancer Treatment Drugs Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Prostate Cancer Treatment Drugs Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Prostate Cancer Treatment Drugs Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2023-2028
Table 30. Johnson & Johnson Corporate Summary
Table 31. Johnson & Johnson Prostate Cancer Treatment Drugs Product Offerings
Table 32. Johnson & Johnson Prostate Cancer Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 33. Astella Corporate Summary
Table 34. Astella Prostate Cancer Treatment Drugs Product Offerings
Table 35. Astella Prostate Cancer Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 36. Sanofi Corporate Summary
Table 37. Sanofi Prostate Cancer Treatment Drugs Product Offerings
Table 38. Sanofi Prostate Cancer Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 39. Ipsen Corporate Summary
Table 40. Ipsen Prostate Cancer Treatment Drugs Product Offerings
Table 41. Ipsen Prostate Cancer Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 42. Bayer Corporate Summary
Table 43. Bayer Prostate Cancer Treatment Drugs Product Offerings
Table 44. Bayer Prostate Cancer Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 45. AstraZeneca Corporate Summary
Table 46. AstraZeneca Prostate Cancer Treatment Drugs Product Offerings
Table 47. AstraZeneca Prostate Cancer Treatment Drugs Revenue (US$, Mn), (2017-2022)
Table 48. Dendreon Corporate Summary
Table 49. Dendreon Prostate Cancer Treatment Drugs Product Offerings
Table 50. Dendreon Prostate Cancer Treatment Drugs Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Prostate Cancer Treatment Drugs Segment by Type in 2021
Figure 2. Prostate Cancer Treatment Drugs Segment by Application in 2021
Figure 3. Global Prostate Cancer Treatment Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Prostate Cancer Treatment Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Prostate Cancer Treatment Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Prostate Cancer Treatment Drugs Revenue in 2021
Figure 8. By Type - Global Prostate Cancer Treatment Drugs Revenue Market Share, 2017-2028
Figure 9. By Application - Global Prostate Cancer Treatment Drugs Revenue Market Share, 2017-2028
Figure 10. By Region - Global Prostate Cancer Treatment Drugs Revenue Market Share, 2017-2028
Figure 11. By Country - North America Prostate Cancer Treatment Drugs Revenue Market Share, 2017-2028
Figure 12. US Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Prostate Cancer Treatment Drugs Revenue Market Share, 2017-2028
Figure 16. Germany Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 17. France Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Prostate Cancer Treatment Drugs Revenue Market Share, 2017-2028
Figure 24. China Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. India Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Prostate Cancer Treatment Drugs Revenue Market Share, 2017-2028
Figure 30. Brazil Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Prostate Cancer Treatment Drugs Revenue Market Share, 2017-2028
Figure 33. Turkey Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Prostate Cancer Treatment Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. Johnson & Johnson Prostate Cancer Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Astella Prostate Cancer Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Sanofi Prostate Cancer Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Ipsen Prostate Cancer Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Bayer Prostate Cancer Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. AstraZeneca Prostate Cancer Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Dendreon Prostate Cancer Treatment Drugs Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
